Facultad de Ciencias Agropecuarias, Universidad de la Salle. Carrera. 7 No. 172-85. Bogotá, Colombia. (Received: November 13, 2014; accepted: January 27, 2016) doi: 10.17533/udea.rccp.v29n2a06 Summary Background: an optimal formulation for vitrifying in vitro-produced (IVP) bovine embryos is currently unavailable. Objective: to estimate whether differences in composition of vitrification solutions may affect the viability of IVP embryos as compared to that of embryos cryopreserved by a conventional slow-freezing method. Methods: bovine IVP embryos were cryopreserved by two methods: 1) a slow controlled-rate (1.5 M ethylene glycol (EG)), or 2) vitrification by using two different vitrification and thawing/warming solutions: (1) Protocol V1: commercial vitrification Kit, and (2) Protocol V2: defined vitrification (20% EG; 20% dimethyl sulfoxide (DMSO); 20% fetal bovine serum (FBS)) and warming (20% FBS; 0.2 M sucrose) solutions. Embryo viability was recorded at 24, 48, and 72 h after thawing/warming by evaluating the number of embryos that re-expanded and developed to the hatching blastocyst stage. Results: embryo survival rate was affected by the method of cryopreservation, where the frequency of embryos that re-expanded at 24 h after thawing/warming was higher for embryos vitrified with protocols V1 and V2 (89.0%, 86.2%, respectively) compared to those cryopreserved by the slow-controlled rate method (73.6%, p<0.05). Similarly, higher percentage of embryos cryopreserved by vitrification hatched at 72 h, where protocol V2 resulted in higher percentage of hatched embryos (84.3%) compared to protocol V1 (64,0%, p<0.05), and both were higher compared to the slowcontrolled rate method (55.2%, p<0.05). Conclusions: the method of cryopreservation and composition of the vitrification solution have a direct effect on the viability of bovine IVP embryos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.